MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10072-023-06731-x

Медицинская библиотека · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023

IVIg-induced headache: prospective study of a large cohort with neurological disorders.

Hasırcı Bayır Buse Rahime, Ünsal Miraç Ayşen, Ağırcan Cansu, Cerrahoğlu Şirin Tuba, Akan Onur, Gürsoy Gizem, Eyigürbüz Tuğba, Mermi Dibek Dilara, Akdağ Gönül, Elmalı Ayşe Deniz, Nazlı Ezgi, Akkoyun Arıkan Fatma, Alpaydın Baslo Sezin, Ağırcan Dilek, Oguz-Akarsu Emel, Ertürk Çetin Özdem, Gesoğlu Demir Tülin, Acıman Demirel Esra, Vurallı Doğa, Deveci Şule, Tanyel Tuba, Mayda Domaç Füsun, Karlı Necdet, Velioğlu Sibel, Baykan Betül, Study Group

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Intravenous immune globulin (IVIg) is frequently used in some neurological diseases and is also the first-line therapy in Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy. We aimed to evaluate the frequency and characteristics of headaches, which is one of the most common side effects of IVIg treatment.

METHODS

Patients who received IVIg treatment for neurological diseases were prospectively enrolled in 23 centers. Firstly, the characteristics of patients with and without IVIg-induced headaches were analyzed statistically. Then, patients with IVIg-induced headaches were classified into three subgroups determined by their history: no primary headache, tension-type headache (TTH), and migraine.

RESULTS

A total of 464 patients (214 women) and 1548 IVIg infusions were enrolled between January and August 2022. The frequency of IVIg-related headaches was 27.37% (127/464). A binary logistic regression analysis performed with significant clinical features disclosed that female sex and fatigue as a side effect were statistically more common in the IVIg-induced headache group. IVIg-related headache duration was long and affected daily living activities more in patients with migraine compared to no primary headache and TTH groups (p = 0.01, respectively).

CONCLUSION

Headache is more likely to occur in female patients receiving IVIg and those who develop fatigue as a side effect during the infusion. Clinicians' awareness of IVIg-related headache characteristics, especially in patients with migraine, may increase treatment compliance.

Для цитирования: Hasırcı Bayır Buse Rahime, Ünsal Miraç Ayşen, Ağırcan Cansu, Cerrahoğlu Şirin Tuba, Akan Onur, Gürsoy Gizem, Eyigürbüz Tuğba, Mermi Dibek Dilara, Akdağ Gönül, Elmalı Ayşe Deniz, Nazlı Ezgi, Akkoyun Arıkan Fatma, Alpaydın Baslo Sezin, Ağırcan Dilek, Oguz-Akarsu Emel, Ertürk Çetin Özdem, Gesoğlu Demir Tülin, Acıman Demirel Esra, Vurallı Doğa, Deveci Şule, Tanyel Tuba, Mayda Domaç Füsun, Karlı Necdet, Velioğlu Sibel, Baykan Betül, Study Group. IVIg-induced headache: prospective study of a large cohort with neurological disorders.. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2023. DOI: 10.1007/s10072-023-06731-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.